ONO-7436 Phase II Study in Japan
NCT00212602 · Status: COMPLETED · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 420
Last updated 2012-06-14
Summary
The purpose of this study is to examine the efficacy and safety of ONO-7436 for the prevention of cancer chemotherapy-induced nausea and vomiting in patients with malignant tumor
Conditions
- Malignant Tumor
Interventions
- DRUG
-
ONO-7436
Sponsors & Collaborators
-
Ono Pharmaceutical Co. Ltd
lead INDUSTRY
Principal Investigators
-
Project Leader, Development Planning · Ono Pharmaceutical Co. Ltd
Study Design
- Allocation
- RANDOMIZED
- Purpose
- PREVENTION
- Masking
- DOUBLE
- Model
- PARALLEL
Eligibility
- Min Age
- 20 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2005-08-31
Countries
- Japan
Study Locations
More Related Trials
-
A Study of Palonosetron for the Prevention of Chemotherapy-Induced Nausea and Vomiting (CINV) in Participants Who Have Experienced CINV(Chemotherapy-Induced Nausea and Vomiting) During the Previous Cycle of Low Emetogenic Chemotherapy (LEC)
NCT01054456 ·Status: COMPLETED ·Phase: PHASE2
-
Study Assessing Fosaprepitant in Advanced NSCLC Patients Treated With Carboplatin Based Chemotherapy
NCT02407600 ·Status: UNKNOWN ·Phase: PHASE2
-
Ondansetron Orodispersible Film for Vomiting Prevention in Pediatric Radiotherapy
NCT07217600 ·Status: RECRUITING ·Phase: PHASE4
-
Ondansetron in Treating Patients With Advanced Cancer and Chronic Nausea and Vomiting Not Caused by Cancer Treatment
NCT00006348 ·Status: COMPLETED ·Phase: PHASE3
-
Comparative Study of Palonosetron With Granisetron as a Control in Patients Receiving Highly Emetogenic Chemotherapy
NCT00359567 ·Status: COMPLETED ·Phase: PHASE3
-
Nano-crystalline Megestrol Acetate for Chemotherapy-induced Nausea and Vomiting
NCT07246070 ·Status: NOT_YET_RECRUITING ·Phase: PHASE2
-
Buccal Film Versus IV Injection Palonosetron for Moderately Emetogenic Chemotherapy Induced Nausea and Vomiting
NCT04592198 ·Status: COMPLETED ·Phase: PHASE2
-
A Study to Evaluate the Efficacy of Anti-emetic Drug Upon the Combination Chemotherapy for Non-small Cell Lung Cancer
NCT02364804 ·Status: COMPLETED
-
Safety and Efficacy of Palonosetron in Preventing Chemotherapy-induced Nausea and Vomiting
NCT00503386 ·Status: COMPLETED ·Phase: PHASE2
-
HR20013 for Nausea and Vomiting Associated With Moderate Emetic Risk Anticancer Agents
NCT06554184 ·Status: COMPLETED ·Phase: PHASE3
-
Ondansetron Plus Dexamethasone With or Without Metoclopramide as Antiemetic Prophylaxis After Receiving Cisplatin
NCT01093690 ·Status: COMPLETED ·Phase: NA
-
Palonosetron in Moderately and Highly Emetogenic Chemotherapy Induced Nausea and Vomiting (Study P04935)(COMPLETED)
NCT00684463 ·Status: COMPLETED ·Phase: PHASE4
-
Study With Palonosetron Alone in Preventing Chemotherapy-induced Nausea and Vomiting in Untreated Patients With Aggressive Non Hodgkin's Lymphomas Who Underwent Moderately Emetogenic Chemotherapy
NCT01018758 ·Status: COMPLETED ·Phase: PHASE2
-
Granisetron Transdermal Patch for Prophylaxis of Nausea and Vomiting in Patients Receiving Oral Anticancer Agents
NCT04472143 ·Status: UNKNOWN ·Phase: PHASE2
-
Olanzapine Plus Fosaprepitant Standard Antiemetic Therapy in the Prevention of Chemotherapy-induced Nausea and Vomiting in Patients Receiving High Emetic Risk Multi-day Chemotherapy: a Multicenter, Randomized, Double-blind, Placebo-controlled, Phase 3 Study
NCT04536558 ·Status: UNKNOWN ·Phase: PHASE3
-
Study Of Prevention of Chemo-Induced Nausea and Vomiting Caused By Moderately Emetogenic Chemotherapy
NCT00104403 ·Status: COMPLETED ·Phase: PHASE2
-
Prospective Study of Palonosetron in Radiation Induced Nausea and Vomiting (RINV)
NCT02388750 ·Status: COMPLETED ·Phase: PHASE2
-
Aprepitant/MK0869 for Prevention of Chemotherapy Induced Nausea and Vomiting Associated With Cisplatin (0869-169)(COMPLETED)
NCT00952341 ·Status: COMPLETED ·Phase: PHASE3
-
Ondansetron (ODF) Versus Ondansetron Intravenously for the Prevention of Chemotherapy-induced Nausea and Vomiting Compare in Children
NCT06208917 ·Status: RECRUITING ·Phase: PHASE3
-
Olanzapine for the Prevention and Treatment of Nausea and Vomiting Induced by Chemotherapy of Lung Cancer
NCT03571126 ·Status: UNKNOWN ·Phase: PHASE4
-
Proof-of-Concept Trial of Palonosetron and Olanzapine Without Dexamethasone for the Prevention of CIN
NCT02970643 ·Status: UNKNOWN ·Phase: NA
-
Akynzeo as Antiemetic Treatment in Patients With Endometrial Cancer
NCT06726291 ·Status: RECRUITING ·Phase: PHASE4
-
Efficacy and Safety of Palonosetron Intravenous in Prevention of Chemotherapy Induced Nausea and Vomiting in Pediatric Patients
NCT01442376 ·Status: COMPLETED ·Phase: PHASE3
-
Efficacy and Safety of Olanzapine for the Treatment of Nausea and Vomiting in Palliative Cancer Care
NCT03679182 ·Status: UNKNOWN ·Phase: PHASE2
-
Treatment Algorithm for Nausea and Vomiting in the Palliative Phase
NCT03017391 ·Status: UNKNOWN ·Phase: PHASE4